B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Mısır AF, Durmuşlar MC, Zerener T, Gün BD. Primary malignant melanoma. Saudi Med J. 2016;37(4):446–449. doi:10.15537/smj.2016.4.15017
   PubMed Web of Science ®Google Scholar
• Naidoo C, Kruger CA, Abrahamse H. Photodynamic therapy for metastatic melanoma treatment: a review. Technol Cancer Res Treat. 2018;17:1533033818791795. doi:10.1177/1533033818791795
   Web of Science ®Google Scholar
• Dash BS, Das S, Chen JP. Photosensitizer-functionalized nanocomposites for light-activated cancer theranostics. Int J Mol Sci. 2021;22(13):6658. doi:10.3390/ijms22136658
   PubMed Web of Science ®Google Scholar
• Sakka SG, van Hout N. Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients. Intensive Care Med. 2006;32(5):766–769. doi:10.1007/s00134-006-0109-6
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang W, Wu X, et al. Dual modal imaging-guided drug delivery system for combined chemo-photothermal melanoma therapy. Int J Nanomed. 2021;16:3457–3472. doi:10.2147/IJN.S306269
   PubMed Web of Science ®Google Scholar
• Campu A, Focsan M, Lerouge F, et al. ICG-loaded gold nano-bipyramids with NIR activatable dual PTT-PDT therapeutic potential in melanoma cells. Colloids Surf B Biointerfaces. 2020;194:111213. doi:10.1016/j.colsurfb.2020.111213
   PubMed Web of Science ®Google Scholar
• Sun Z, Wang X, Liu J, et al. ICG/l-arginine encapsulated PLGA nanoparticle-thermosensitive hydrogel hybrid delivery system for cascade cancer photodynamic-NO therapy with promoted collagen depletion in tumor tissues. Mol Pharm. 2021;18(3):928–939. doi:10.1021/acs.molpharmaceut.0c00937
   PubMed Web of Science ®Google Scholar
• Persico MG, Marenco M, De Matteis G, et al. (99m)Tc-(68)Ga-ICG-Labelledmacroaggregates and nanocolloids of human serum albumin: synthesis procedures of a trimodal imaging agent using commercial kits. Contrast Media Mol Imaging. 2020;2020:3629705. doi:10.1155/2020/3629705
   PubMed Web of Science ®Google Scholar
• Li R, He Y, Zhang S, Qin J, Wang J. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment. Acta pharmaceutica Sinica B. 2018;8(1):14–22. doi:10.1016/j.apsb.2017.11.009
   PubMed Web of Science ®Google Scholar
• Le QV, Lee J, Lee H, Shim G, Oh YK. Cell membrane-derived vesicles for delivery of therapeutic agents. Acta pharmaceutica Sinica B. 2021;11(8):2096–2113. doi:10.1016/j.apsb.2021.01.020
   PubMed Web of Science ®Google Scholar
• Sushnitha M, Evangelopoulos M, Tasciotti E, Taraballi F. Cell membrane-based biomimetic nanoparticles and the immune system: immunomodulatory interactions to therapeutic applications. Front Bioeng Biotechnol. 2020;8:627. doi:10.3389/fbioe.2020.00627
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang P, Wei Y, et al. Cell-membrane-display nanotechnology. Adv Healthcare Mater. 2021;10(1):e2001014. doi:10.1002/adhm.202001014
   Web of Science ®Google Scholar
• Jin J, Krishnamachary B, Barnett JD, et al. Human cancer cell membrane-coated biomimetic nanoparticles reduce fibroblast-mediated invasion and metastasis and induce T-Cells. ACS Appl Mater Interfaces. 2019;11(8):7850–7861. doi:10.1021/acsami.8b22309
   PubMed Web of Science ®Google Scholar
• Tapeinos C, Tomatis F, Battaglini M, et al. Cell membrane-coated magnetic nanocubes with a homotypic targeting ability increase intracellular temperature due to ROS scavenging and act as a versatile theranostic system for glioblastoma multiforme. Adv Healthcare Mater. 2019;8(18):e1900612. doi:10.1002/adhm.201900612
   Web of Science ®Google Scholar
• Guo Q, Wang L, Xu P, et al. Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse. Oncoimmunology. 2020;9(1):1841392. doi:10.1080/2162402X.2020.1841392
   PubMed Web of Science ®Google Scholar
• Gao J, Chu D, Wang Z. Cell membrane-formed nanovesicles for disease-targeted delivery. J Control Release. 2016;224:208–216. doi:10.1016/j.jconrel.2016.01.024
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Jurado-Sanchez B, Lin X, Wu Z, He Q. Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small. 2016;12(30):4056–4062. doi:10.1002/smll.201600624
   PubMed Web of Science ®Google Scholar
• Wei R, Jiang G, Lv M, et al. TMTP1-modified indocyanine green-loaded polymeric micelles for targeted imaging of cervical cancer and metastasis sentinel lymph node in vivo. Theranostics. 2019;9(24):7325–7344. doi:10.7150/thno.35346
   PubMed Web of Science ®Google Scholar
• Li S, Jiang W, Yuan Y, et al. Delicately designed cancer cell membrane-camouflaged nanoparticles for targeted (19)F MR/PA/FL imaging-guided photothermal therapy. ACS Appl Mater Interfaces. 2020;12(51):57290–57301. doi:10.1021/acsami.0c13865
   PubMed Web of Science ®Google Scholar
• Schwartzentruber DJ, Lawson DH, Richards JM, et al. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med. 2011;364(22):2119–2127. doi:10.1056/NEJMoa1012863
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CM, Luk BT, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14(4):2181–2188. doi:10.1021/nl500618u
   PubMed Web of Science ®Google Scholar
• Peng LH, Zhang YH, Han LJ, et al. Cell membrane capsules for encapsulation of chemotherapeutic and cancer cell targeting in vivo. ACS Appl Mater Interfaces. 2015;7(33):18628–18637. doi:10.1021/acsami.5b05065
   PubMed Web of Science ®Google Scholar
• Li D, Wang Y, Li C, et al. Cancer-speci fi c calcium nanoregulator suppressing the generation and circulation of circulating tumor cell clusters for enhanced anti-metastasis combinational chemotherapy. Acta pharmaceutica Sinica B. 2021;11(10):3262–3271. doi:10.1016/j.apsb.2021.04.009
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhu Y, Xu X, et al. Surface PEGylated cancer cell membrane-coated nanoparticles for codelivery of curcumin and doxorubicin for the treatment of multidrug resistant esophageal carcinoma. Front Cell Dev Biol. 2021;9:688070. doi:10.3389/fcell.2021.688070
   PubMed Web of Science ®Google Scholar
• Hu J, Luo H, Qu Q, et al. Cell membrane-inspired polymeric vesicles for combined photothermal and photodynamic prostate cancer therapy. ACS Appl Mater Interfaces. 2020;12(38):42511–42520. doi:10.1021/acsami.0c11636
   PubMed Web of Science ®Google Scholar
• Souchek JJ, Wojtynek NE, Payne WM, et al. Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft. Acta biomaterialia. 2018;75:323–333. doi:10.1016/j.actbio.2018.06.016
   PubMed Web of Science ®Google Scholar
• Zou S, Wang B, Wang C, Wang Q, Zhang L. Cell membrane-coated nanoparticles: research advances. Nanomedicine. 2020;15(6):625–641. doi:10.2217/nnm-2019-0388
   PubMed Web of Science ®Google Scholar
• Martin JD, Cabral H, Stylianopoulos T, Jain RK. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges. Nat Rev Clin Oncol. 2020;17(4):251–266. doi:10.1038/s41571-019-0308-z
   PubMed Web of Science ®Google Scholar